Bylined article by Washington, DC Intellectual Property partner Gary Hnath discusses the use of the International Trade Commission’s “Section 337” as a tool to protect medical device firms’ intellectual property.
Downloads –
Latest Perspectives
Stay up-to-date on our perspectives
Subscribe to Email